UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3 (Final))*
INTERLEUKIN GENETICS, INC.
--------------------------
(Name of Issuer)
Common Stock, no par value
--------------------------
(Title of Class of Securities)
458738 10 1
-----------
(CUSIP Number)
MSSI LLC
c/o Richard L. Fisher
299 Park Avenue
New York, NY 10017
(212) 752-5000
copy to:
John N. Turitzin
Paul, Hastings, Janofsky & Walker LLP
75 East 55th Street
New York, NY 10022
(212) 318-6000
--------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
July 14, 2000
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), (f) or (g), check the following box / /.
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 6 Pages
NYC55/6324.1
<PAGE>
CUSIP No. 458738 10 1 SCHEDULE 13D
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MSSI LLC 13-4075839
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / /
(b) /X/
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS
OO
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) or 2(e) / /
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
- 0 -
NUMBER OF -----------------------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY - 0 -
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH - 0 -
-----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
- 0 -
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
- 0 -
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / /
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
- 0 -
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
OO
--------------------------------------------------------------------------------
Page 2 of 6 Pages
NYC55/6324.1
<PAGE>
Amendment No. 3 (Final)
to
Schedule 13D
This Amendment No. 3 to Schedule 13D amends and supplements the
original Schedule 13D, dated September 13, 1999, as amended by Amendment No.1
thereto, dated November 12, 1999, and as amended by Amendment No. 2 thereto,
dated March 14, 2000, filed on behalf of MSSI LLC (the "Company"), with respect
to the ownership of Common Stock, no par value ("Common Stock"), of Interleukin
Genetics, Inc., a Texas corporation (the "Issuer").
I. Item 5 of the Schedule 13D "Interest in Securities of the Issuer" is amended
and restated as follows:
(a) and (b). As of the close of business on July 14, 2000, the Company
did not beneficially own or otherwise have the sole or shared power to vote or
dispose of any shares of Common Stock.
(c). From March 21, 2000 through April 6, 2000, the Company sold
164,800 shares of Common Stock in open market transactions as set forth on
Schedule I attached hereto. On July 14, 2000, the Company distributed its
remaining 1,335,200 shares of Common Stock to its members in proportion to each
member's percentage interest in the Company as set forth on Schedule II attached
hereto. No consideration was received by the Company in exchange for the shares
of Common Stock.
(d). Not applicable.
(e). As of the close of business on July 14, 2000, the Company ceased
to be the beneficial owner of more than five percent of the Issuer's outstanding
shares of Common Stock. Accordingly, the Company intends not to further amend
its report on Schedule 13D to reflect changes in the facts set forth therein
which may occur after the date hereof.
Page 3 of 6 Pages
NYC55/6324.1
<PAGE>
SCHEDULE I
Date Amount of Securities Sold Net Proceeds per Share
--------------------------------------------------------------------------------
March 21, 2000 10,000 $10.25
--------------------------------------------------------------------------------
March 22, 2000 10,000 11.31
--------------------------------------------------------------------------------
March 23, 2000 20,000 12.64
--------------------------------------------------------------------------------
March 24, 2000 10,000 12.61
--------------------------------------------------------------------------------
March 27, 2000 12,500 12.70
--------------------------------------------------------------------------------
March 28, 2000 14,000 11.64
--------------------------------------------------------------------------------
March 29, 2000 10,000 10.42
--------------------------------------------------------------------------------
March 30, 2000 10,000 9.57
--------------------------------------------------------------------------------
March 31, 2000 20,000 9.22
--------------------------------------------------------------------------------
April 3, 2000 10,000 10.01
--------------------------------------------------------------------------------
April 4, 2000 8,900 8.37
--------------------------------------------------------------------------------
April 5, 2000 9,400 8.09
--------------------------------------------------------------------------------
April 6, 2000 20,000 8.13
--------------------------------------------------------------------------------
Total 164,800
--------------------------------------------------------------------------------
Page 4 of 6 Pages
NYC55/6324.1
<PAGE>
SCHEDULE II
Member Percentage Interest Shares of Common Stock
------ ------------------- ----------------------
--------------------------------------------------------------------------------
Arnold Fisher 19% 253,688
--------------------------------------------------------------------------------
Richard L. Fisher 19% 253,688
--------------------------------------------------------------------------------
M. Anthony Fisher 19% 253,688
--------------------------------------------------------------------------------
Kenneth Fisher 19% 253,688
--------------------------------------------------------------------------------
Steven Fisher 19% 253,688
--------------------------------------------------------------------------------
Martin L. Edelman 5% 66,760
--------------------------------------------------------------------------------
Page 5 of 6 Pages
NYC55/6324.1
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
MSSI LLC
By: /s/ M. Anthony Fisher
---------------------
Name: M. Anthony Fisher
Title: Managing Member
Dated: July 20, 2000
Page 6 of 6 Pages
NYC55/6324.1
